Michèle Flournoy and Joe Biden (source) by Thomas NeuburgerDespite all the focus on domestic and economic matters in the current election, foreign policy, never really discussed, should bear at least equal scrutiny.
by Thomas NeuburgerI’m working on a book-length project that includes a look at our soon-to-be post-Trump world. These are preliminary notes for that part of the project.1. The World Without Trump won’t be a world without Trump. (For the exception, see below.) Trump will not go away. He'll persist as a pest that’s driven from the desk but not from the room he’s in.
The story that started the latest round of madness by Thomas NeuburgerIf you're confused by the welter of reports around the Hunter Biden-purloined (or forgotten) laptop story, don't be embarrassed. The reporting is not just confusing, but confusingly told.
Amy Coney Barrett, Liar and Climate Denier, Disqualifies Herself for Any Position Involving Factual Evaluation
by Thomas NeuburgerIt couldn't be more simple. When Notre Dame Law professor and Trump Supreme Court nominee Amy Coney Barrett was asked at her Senate hearing about climate change (one of the few times senators questioned her on this subject), she had this to say:“I don’t think I am competent to opine on what causes global warming or not.”Every human on the planet is "competent to opine" on what causes global warming.
The Social Justice Criticism of Amy Coney Barrett Hides All of the Rest of What's Wrong with Her Nomination
Capitol reporter Jamie Dupree's tweet referencing the Sept.
Saagar Enjeti explains the importance of the U.S. Chamber of Commerce's quiet decision to back Democratic candidates by Thomas NeuburgerOne of the more underappreciated pieces of news in a week that exploded with news — leak of Trump's taxes, the presidential debate, the presidential disease — was this, that a long-time strategist for the U.S.
From the source: "The figure above includes 10 vaccine candidates already in Phase I, 4 candidates in combined Phase I/II trials, 2 candidates in Phase II and 3Candidates in Phase II/III (Moderna is already for a total of 18 candidates in clinical phases."by Thomas NeuburgerThe fastest vaccine ever developed was the mumps vaccine, and i